Hua Medicine Ltd. reported unaudited consolidated earnings results for the six months ended June 30, 2018. For the period the company reported Loss before tax was RMB 1,506,939,000 compared to RMB 228,764,000 a year ago. Loss and total comprehensive expense for the period was RMB 1,506,939,000 compared to RMB 228,764,000 a year ago. Adjusted loss was RMB 115,236,000 compared to RMB 49,519,000 a year ago. Loss and total comprehensive expense for the period attributable to owners of the company was RMB 1,505,667,000 compared to RMB 224,782,000 a year ago. Loss of RMB 13.58 per basic and diluted share compared to RMB 2.24 per basic and diluted share a year ago. Net cash used in operating activities was RMB 120,873,000 compared to RMB 64,570,000 a year ago. Purchase of plant and equipment was RMB 706,000 compared to RMB 1,061,000 a year ago.